| Stock | Symbol | Price | Chart (24H) | Chart (5D) | 52 Week Range | Change % | Change | Open | Close | High | Low | Volume | Previous Close | Marketcap | Exchange | 52 Weeks High | 52 Weeks Low | Currency | Dividend Yield | Dividend Rate | EPS | Shares | Company | Industry | Type | Sector | Employees | City | State | Country | Phone | Address | Zip Code | Website | Last Updated |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Biogen Inc. BIIB | BIIB | $197.78 | -1.42% | $2.84 | $200.28 | $200.62 | $200.62 | $194.46 | 1.44M | $200.62 | $28.70B | NMS | $291.54 | $187.16 | USD | 13.79 | 145.11M | Biogen Inc. | Drug Manufacturers—General | EQUITY | Healthcare | 9.61K | Cambridge | MA | United States | 617 679 2000 | 225 Binney Street | 02142 | https://www.biogen.com | 2 days ago |